STTK
Shattuck Labs, Inc. - Common Stock (STTK)
$49
About Shattuck Labs, Inc. - Common Stock (STTK)
Shattuck Labs, Inc. is a clinical-stage biotechnology company, which engages in the research and development of potential treatments for inflammatory and immune-mediated diseases. It focuses on developing a potential first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.
Details
Daily high
$5.11
Daily low
$4.44
Price at open
--
52 Week High
$8.33
52 Week Low
$1.72
Market cap
516.9M
Dividend yield
-
Volume
8
Avg. volume
1.0M
P/E ratio
-10.12
Shattuck Labs, Inc. - Common Stock News
Details
Daily high
$5.11
Daily low
$4.44
Price at open
--
52 Week High
$8.33
52 Week Low
$1.72
Market cap
516.9M
Dividend yield
-
Volume
8
Avg. volume
1.0M
P/E ratio
-10.12